Improved survival in BRCA2 carriers with ovarian cancer
- 8 December 2006
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 6 (1) , 113-119
- https://doi.org/10.1007/s10689-006-9112-x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesCancer, 2005
- Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases – preliminary reportEuropean Journal Of Cancer, 2005
- BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based studyEuropean Journal Of Cancer, 2004
- One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern SwedenEuropean Journal Of Cancer, 2004
- Hereditary ovarian cancer in PolandInternational Journal of Cancer, 2003
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse PopulationsAmerican Journal of Human Genetics, 2000
- AnAlu-mediated 7.1 kb deletion ofBRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10Genes, Chromosomes and Cancer, 2000
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Characteristics Relating to Ovarian Cancer Risk: Implications for Prevention and DetectionGynecologic Oncology, 1994